Table 4 AUC/Hosmer and lemeshow/Brier score in all cohorts.

From: Construction and validation of a novel model for guiding targeted combined immunotherapy in advanced hepatocellular carcinoma

  

AUC

95%CI

Hosmer and Lemeshow P value

Brier score

Lower

Upper

  

Training cohort

Combined

0.933

0.893

0.973

0.8398

0.00907

ALBI

0.755

0.671

0.835

0.155

0.185

AFP

0.642

0.551

0.764

0.105

0.128

Internal validation

Combined

0.941

0.879

0.963

0.9921

0.0695

ALBI

0.712

0.626

0.821

0.3598

0.1574

AFP

0.602

0.514

0.762

0.4856

0.099

External validation

Combined

0.937

0.864

0.972

0.5663

0.0714

ALBI

0.852

0.648

0.911

0.0356

0.2057

AFP

0.824

0.628

0.902

0.0457

0.0682

Back to article page